Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tenghuangjiangu tablets
- Development stage
- Phase 4
- Lead developer
- Fangsheng Pharmaceutical
- Administration
- Oral
01
Overview
Tenghuangjiangu tablets (藤黄健骨片) is a proprietary Chinese herbal medicine developed and manufactured by Hunan Fangsheng Pharmaceutical. It is formulated with seven traditional Chinese medicinal herbs, including Radix Rehmanniae Praeparata (熟地黄), Pyrola calliantha (鹿衔草), Drynaria fortunei (骨碎补), Cistanche deserticola (肉苁蓉), Epimedium brevicornu (淫羊藿), Spatholobus suberectus (鸡血藤), and Raphanus sativus (莱菔子). The formulation is primarily indicated for the treatment of osteoarthritis (particularly knee osteoarthritis), hypertrophic spondylitis, cervical spondylosis, calcaneal spur, proliferative arthritis, and Kashin-Beck disease. It acts by nourishing the kidneys, promoting blood circulation, and relieving pain. Clinical and preclinical studies suggest that Tenghuangjiangu tablets can slow the progression of osteoarthritis by inhibiting catabolic factors, reducing subchondral bone sclerosis, and suppressing inflammatory pathways such as TNF-alpha/IL-6/JAK2/STAT3.
- Brand names
- Fangshengtang方盛堂
- Other names
- Tenghuang Jiangu TabletsTenghuangjiangu Pian藤黄健骨片
02
Targets
CTSK (Cathepsin K)IL-6 (Interleukin 6)RELA (Nuclear Factor Kappa B Subunit p65)SRC (Proto-oncogene tyrosine-protein kinase Src)STAT3 (Signal Transducer and Activator of Transcription 3)
Beyond the preview
Go deeper on Tenghuangjiangu tablets.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tenghuangjiangu tablets.